Business Description
Inspire Medical Systems Inc
NAICS : 334510
SIC : 3845
Description
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.26 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.78 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 47.08 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 35.1 | |||||
| 3-Year EBITDA Growth Rate | -4.4 | |||||
| 3-Year EPS without NRI Growth Rate | -0.9 | |||||
| 3-Year FCF Growth Rate | 11.2 | |||||
| 3-Year Book Growth Rate | 6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 58.96 | |||||
| 9-Day RSI | 47.41 | |||||
| 14-Day RSI | 44.45 | |||||
| 6-1 Month Momentum % | -30.5 | |||||
| 12-1 Month Momentum % | -22.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.62 | |||||
| Quick Ratio | 5.15 | |||||
| Cash Ratio | 4.19 | |||||
| Days Inventory | 149.72 | |||||
| Days Sales Outstanding | 38.99 | |||||
| Days Payable | 105.27 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.4 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 85.39 | |||||
| Operating Margin % | -13.85 | |||||
| Net Margin % | -14.6 | |||||
| ROE % | -19.59 | |||||
| ROA % | -15.38 | |||||
| ROIC % | -83.37 | |||||
| ROC (Joel Greenblatt) % | -103.76 | |||||
| ROCE % | -16.78 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 16.65 | |||||
| PB Ratio | 22.2 | |||||
| Price-to-Tangible-Book | 22.22 | |||||
| EV-to-EBIT | -122.36 | |||||
| EV-to-EBITDA | -126.83 | |||||
| EV-to-Revenue | 16.9 | |||||
| EV-to-Forward-Revenue | 9.88 | |||||
| EV-to-FCF | -218.41 | |||||
| Price-to-Net-Current-Asset-Value | 25.44 | |||||
| Price-to-Net-Cash | 38.41 | |||||
| Earnings Yield (Greenblatt) % | -0.82 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:INSP
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 300.851 | ||
| EPS (TTM) ($) | -1.61 | ||
| Beta | 1.66 | ||
| Volatility % | 41.85 | ||
| 14-Day RSI | 44.45 | ||
| 14-Day ATR ($) | 8.659745 | ||
| 20-Day SMA ($) | 187.21 | ||
| 12-1 Month Momentum % | -22.48 | ||
| 52-Week Range ($) | 142.74 - 286.285 | ||
| Shares Outstanding (Mil) | 28.79 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Inspire Medical Systems Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Inspire Medical Systems Inc Analysis
Share your researchHeadlines
See More
No news.